Gsa Capital Partners LLP Ocugen, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Ocugen, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 1,728,561 shares of OCGN stock, worth $1.78 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,728,561
Previous 1,638,033
5.53%
Holding current value
$1.78 Million
Previous $1.16 Million
44.94%
% of portfolio
0.12%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding OCGN
# of Institutions
106Shares Held
62.1MCall Options Held
585KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$15.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$5.21 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.28 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$3.59 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $223M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...